Pages that link to "Q53347755"
Jump to navigation
Jump to search
The following pages link to Regulation of E-cadherin expression by VHL and hypoxia-inducible factor. (Q53347755):
Displaying 50 items.
- Loss of PL6 protein expression in renal clear cell carcinomas and other VHL-deficient tumours (Q24299088) (← links)
- Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition (Q24301382) (← links)
- HSulf-1 modulates FGF2- and hypoxia-mediated migration and invasion of breast cancer cells (Q24338405) (← links)
- State of the science: an update on renal cell carcinoma (Q24630685) (← links)
- The VHL tumor suppressor: master regulator of HIF (Q24634592) (← links)
- A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition (Q24649050) (← links)
- Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (Q26747806) (← links)
- Role of nuclear receptors in breast cancer stem cells (Q26750359) (← links)
- c-Jun N-Terminal Kinases Mediate a Wide Range of Targets in the Metastatic Cascade (Q26998420) (← links)
- Renal tubular HIF-2α expression requires VHL inactivation and causes fibrosis and cysts (Q27309141) (← links)
- Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack (Q28067549) (← links)
- Choosing the right cell line for renal cell cancer research (Q28073283) (← links)
- Evaluation of HIF-1 inhibitors as anticancer agents (Q28253053) (← links)
- VHL inactivation induces HEF1 and Aurora kinase A (Q28294037) (← links)
- Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? (Q29547559) (← links)
- The metalloprotease meprinbeta processes E-cadherin and weakens intercellular adhesion (Q33334334) (← links)
- Expression of BNIP3 in invasive breast cancer: correlations with the hypoxic response and clinicopathological features (Q33463900) (← links)
- Differences in regulation of tight junctions and cell morphology between VHL mutations from disease subtypes (Q33481999) (← links)
- Hypoxia, inflammation, and the tumor microenvironment in metastatic disease (Q33576030) (← links)
- Inhibition of hypoxia-inducible factor-1alpha (HIF-1alpha) protein synthesis by DNA damage inducing agents (Q33580209) (← links)
- Hypoxia Induces autophagic cell death through hypoxia-inducible factor 1α in microglia (Q33599541) (← links)
- The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1 (Q33673803) (← links)
- Loss of myeloid cell-derived vascular endothelial growth factor accelerates fibrosis (Q33732623) (← links)
- Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers (Q33796825) (← links)
- Involvement of members of the cadherin superfamily in cancer (Q33899441) (← links)
- Development of flexible-heteroarotinoids for kidney cancer (Q33926659) (← links)
- Synergistic signaling of tumor cell invasiveness by hepatocyte growth factor and hypoxia. (Q33946966) (← links)
- Biological characteristics of prostate cancer cells are regulated by hypoxia-inducible factor 1α (Q33967632) (← links)
- Von Hippel-Lindau syndrome: molecular mechanisms of the disease (Q34104118) (← links)
- HIF-1α Confers Aggressive Malignant Traits on Human Tumor Cells Independent of Its Canonical Transcriptional Function (Q34586733) (← links)
- Hypoxia and hypoxia mimetics decrease aquaporin 5 (AQP5) expression through both hypoxia inducible factor-1α and proteasome-mediated pathways (Q34613109) (← links)
- The von Hippel-Lindau tumor suppressor gene product represses oncogenic beta-catenin signaling in renal carcinoma cells (Q35080738) (← links)
- Ubiquitin pathway in VHL cancer syndrome (Q35082720) (← links)
- Ablation of the p16(INK4a) tumour suppressor reverses ageing phenotypes of klotho mice (Q35574809) (← links)
- Cadherin expression, vectorial active transport, and metallothionein isoform 3 mediated EMT/MET responses in cultured primary and immortalized human proximal tubule cells (Q35585519) (← links)
- Two sides to every story: the HIF-dependent and HIF-independent functions of pVHL. (Q35589987) (← links)
- Reactive oxygen species promote ovarian cancer progression via the HIF-1α/LOX/E-cadherin pathway (Q35632587) (← links)
- VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail (Q35641669) (← links)
- HIF-2alpha downregulation in the absence of functional VHL is not sufficient for renal cell differentiation (Q35891283) (← links)
- Renal cancer: oxygen meets metabolism (Q35907065) (← links)
- Pathophysiological Consequences of HIF Activation: HIF as a modulator of fibrosis (Q35928851) (← links)
- HIF1α deficiency reduces inflammation in a mouse model of proximal colon cancer (Q36090805) (← links)
- Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy (Q36220497) (← links)
- The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis (Q36300487) (← links)
- The role of hypoxia-inducible factor-2 in digestive system cancers (Q36347140) (← links)
- Human Renal Normal, Tumoral, and Cancer Stem Cells Express Membrane-Bound Interleukin-15 Isoforms Displaying Different Functions. (Q36480193) (← links)
- VHL and p53: tumor suppressors team up to prevent cancer (Q36483621) (← links)
- Hypoxia signalling in cancer and approaches to enforce tumour regression (Q36488739) (← links)
- HIFing the brakes: therapeutic opportunities for treatment of human malignancies (Q36493913) (← links)
- The "Sharp" blade against HIF-mediated metastasis. (Q36581657) (← links)